I
229.22
-11.93 (-4.95%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Bullish | Bearish |
| Medical Devices (Global) | Bullish | Bearish | |
| Stock | Inspire Medical Systems, Inc. | Bullish | - |
|
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| 52 Weeks Range |
123.27 - 330.00
|
|
| Price Target Range | ||
| High | 285.00 (RBC Capital, 24.33%) | Outperform |
| Median | 278.00 (21.28%) | |
| Low | 250.00 (Mizuho, 9.07%) | Buy |
| 250.00 (Morgan Stanley, 9.07%) | Overweight | |
| Average | 268.60 (17.18%) | |
| Total | 2 Buy, 2 Overweight, 1 Outperform | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| RBC Capital | 19 Apr 2024 | 285.00 (24.33%) | Outperform | 229.22 |
| Mizuho | 27 Mar 2024 | 250.00 (9.07%) | Buy | 213.50 |
| 07 Feb 2024 | 250.00 (9.07%) | Buy | 202.16 | |
| Truist Securities | 20 Mar 2024 | 280.00 (22.15%) | Buy | 197.56 |
| 07 Feb 2024 | 280.00 (22.15%) | Buy | 202.16 | |
| Morgan Stanley | 19 Mar 2024 | 250.00 (9.07%) | Overweight | 204.45 |
| Keybanc | 06 Feb 2024 | 278.00 (21.28%) | Overweight | 226.00 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| NELSON MARILYN C | - | - | 0 | 0 |
| Aggregate Net Quantity | 0 | |||
| Aggregate Net Value ($) | 0 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| NELSON MARILYN C | Director | 29 Apr 2024 | Option execute | 1,175 | - | - |
| Date | Type | Details |
|---|---|---|
| 30 Apr 2024 | Announcement | Inspire Medical Systems, Inc. to Present at the BofA Securities 2024 Health Care Conference |
| 02 Apr 2024 | Announcement | Inspire Medical Systems, Inc. to Report First Quarter 2024 Financial Results on May 7, 2024 |
| 05 Mar 2024 | Announcement | Inspire Medical Systems, Inc. to Present at the KeyBanc Life Sciences & MedTech Investor Forum |
| 06 Feb 2024 | Announcement | Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results and Reaffirms 2024 Outlook |
| 05 Feb 2024 | Announcement | Inspire Medical Systems, Inc. Announces Chair Marilyn Carlson Nelson to Retire and Timothy P. Herbert named Chair and Chief Executive Officer |
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |